PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma
NCT00512980 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-12-03
Summary
A randomized phase II study of prednisone, vinblastine, doxorubicin, and gemcitabine in patients with intermediate stage Hodgkin's lymphoma
Conditions
Interventions
- DRUG
- DRUG
-
vinblastine
- DRUG
-
doxorubicin
- DRUG
Sponsors & Collaborators
-
University of Cologne
lead OTHER
Principal Investigators
-
Andreas Engert, Prof · University of Cologne
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2013-11-30
Countries
- Germany
Study Locations
More Related Trials
-
Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)
NCT05008224 ·Status: COMPLETED ·Phase: PHASE2
-
Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach
NCT00250718 ·Status: TERMINATED ·Phase: PHASE2
-
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
NCT05180097 ·Status: RECRUITING ·Phase: PHASE2
-
Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma
NCT00306111 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL
NCT01358747 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00006029 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
NCT00148018 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Study on HIV-related Hodgkin Lymphoma
NCT01468740 ·Status: UNKNOWN ·Phase: PHASE2
-
Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma
NCT00920153 ·Status: TERMINATED ·Phase: PHASE3
-
HD17 for Intermediate Stage Hodgkin Lymphoma
NCT01356680 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
NCT00002715 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
NCT01040871 ·Status: COMPLETED ·Phase: PHASE2
-
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
NCT00972478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
NCT01746173 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
NCT00974792 ·Status: UNKNOWN ·Phase: PHASE2
-
PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL
NCT04624984 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
NCT01132807 ·Status: COMPLETED ·Phase: PHASE2
-
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
NCT05144347 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
NCT01944943 ·Status: TERMINATED ·Phase: PHASE2
-
Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma
NCT00299182 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma
NCT02867618 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Relapsed and/or Refractory Non-Hodgkin Lymphoma Study
NCT00837174 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma
NCT02082977 ·Status: TERMINATED ·Phase: PHASE1
-
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
NCT00388349 ·Status: COMPLETED ·Phase: PHASE2
-
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
NCT05922904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2